Variability of therapeutic response

Factors Influencing Therapeutic Response Variability
📌 The environment is inherently heterogeneous and variable, contrasting with clinical trials which often aim to homogenize populations for testing medications.
📌 Prescribing a drug depends on three main factors: the prescriber's experience, the patient's characteristics (age, sex, condition, pathology), and evidence-based medicine from clinical studies.
📌 Clinical studies often use ideal conditions and ideal patients, which can sometimes distance the findings from the reality of daily clinical practice, necessitating a balance between ideal findings and practical application.

Principles of Rational Prescription
📌 A rational prescription must first address if the intervention is efficacious, safe, and cost-effective.
📌 Efficacy is evaluated first, followed by safety (analyzing adverse effects and balancing risk vs. benefit), and finally cost-effectiveness (considering drug cost and convenience/daily dosing).
📌 The second critical question is whether the patient resembles those included in the clinical trials for that specific drug.

Causes of Therapeutic Failure
📌 Potential causes of failure are numerous, starting with pharmacotechnical production issues or confirming the indication of the medication for the patient's specific pathology.
📌 Posology schedule and convenience are frequent failure points; complex dosing (e.g., four times daily chronically) significantly impacts therapeutic adherence.
📌 Other causes include issues with the route of administration (e.g., using an oral formulation not intended for that route), drug interactions, and whether the underlying disease has evolved or become resistant.

Pharmacokinetic Influences on Variability
📌 Pharmacokinetics (Absorption, Distribution, Metabolism, Elimination) introduces variability through factors like drug release form (immediate vs. prolonged), gastric emptying rate (affected by pregnancy), and competition for absorption sites.
📌 Variability in Distribution is linked to plasma protein concentration and changes in the volume of distribution, as well as permeability alterations in barriers like the blood-brain barrier (more permeable in newborns).
📌 Metabolism variability is often related to Cytochrome P450 enzymes, where inducers or inhibitors can alter drug breakdown; Phase I reactions are notably altered in the elderly population.

Pharmacodynamic and Genetic Influences
📌 Pharmacodynamics variability stems from differences in receptor type and number, which can change based on age or prior treatments (up- or down-regulation).
📌 Pharmacogenetics studies the role of individual gene variation in drug response, focusing on metabolizer status, but should not be viewed in isolation, as it only represents one part of the overall variability picture ("seeing the tree and not the forest").
📌 The concept of variability has evolved from focusing only on pharmacokinetic factors to incorporating pharmacodynamic, environmental, patient factors, and finally genetic factors.

Key Points & Insights
➡️ A rational prescription requires synthesizing genetic, environmental, demographic, and clinical information to ensure the right drug, right patient, right dose.
➡️ When investigating therapeutic failure, check factors like adherence (often linked to dosing convenience) and drug interactions before concluding the patient has developed resistance (which is relatively infrequent).
➡️ Medication response variability is multifaceted; it should never be explained by a single cause but understood as a mixture of pharmacokinetic, pharmacodynamic, and patient-specific factors (both intra- and inter-individual).

📸 Video summarized with SummaryTube.com on Mar 06, 2026, 22:45 UTC